People With Unexplained Abdominal Pain Have Lower Beta-Endorphin in Their Spinal Fluid

CSF beta-endorphin was significantly reduced in patients with functional abdominal pain, while met-enkephalin and dynorphin were normal — suggesting a specific deficit in central pain control.

Jørgensen, L S et al.·Scandinavian journal of gastroenterology·1993·Moderate EvidenceCross-Sectional
RPEP-00265Cross SectionalModerate Evidence1993RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Cross-Sectional
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

CSF beta-endorphin was significantly decreased in functional abdominal pain patients. Met-enkephalin and dynorphin were unchanged. Pain sensitivity was increased.

Key Numbers

How They Did This

CSF was collected from 9 functional abdominal pain patients and 9 controls during spinal analgesia for minor surgery. Three opioid peptides were measured by RIA. Pain sensitivity was tested.

Why This Research Matters

This provides biological evidence that functional abdominal pain involves a real deficit in the body's pain-control system, not just a psychological problem.

The Bigger Picture

Functional abdominal pain is often dismissed as "just stress" or psychological. Finding a measurable opioid peptide deficit validates it as a real neurobiological condition and points toward potential treatments.

What This Study Doesn't Tell Us

Very small sample (9 per group). Cross-sectional design cannot prove causation. Controls were surgical patients, not completely healthy. Only one CSF sample per patient.

Questions This Raises

  • ?Could beta-endorphin supplementation or enhancement help these patients?
  • ?Is this opioid deficit cause or consequence of chronic pain?

Trust & Context

Key Stat:
Beta-endorphin deficit CSF beta-endorphin specifically reduced while other opioid peptides remained normal in functional abdominal pain
Evidence Grade:
Moderate — small but well-controlled study measuring CSF biomarkers in a difficult-to-study patient population.
Study Age:
Published in 1993 (33 years ago). Central opioid deficits in functional pain disorders are now a recognized concept.
Original Title:
Decreased cerebrospinal fluid beta-endorphin and increased pain sensitivity in patients with functional abdominal pain.
Published In:
Scandinavian journal of gastroenterology, 28(9), 763-6 (1993)
Database ID:
RPEP-00265

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

A snapshot of a population at one point in time.

What do these levels mean? →

Frequently Asked Questions

What is functional abdominal pain?

Pain in the abdomen that persists despite no abnormality found on standard tests (endoscopy, imaging, blood work). It was often dismissed as psychological, but this study shows a real biological deficit.

Could this lead to treatment?

Yes — if the problem is low beta-endorphin, treatments that boost the body's natural opioid production (like exercise, certain medications, or neurostimulation) could specifically target the deficit.

Read More on RethinkPeptides

Cite This Study

RPEP-00265·https://rethinkpeptides.com/research/RPEP-00265

APA

Jørgensen, L S; Bach, F W; Christiansen, P; Raundahl, U; Ostgaard, S; Ekman, R. (1993). Decreased cerebrospinal fluid beta-endorphin and increased pain sensitivity in patients with functional abdominal pain.. Scandinavian journal of gastroenterology, 28(9), 763-6.

MLA

Jørgensen, L S, et al. "Decreased cerebrospinal fluid beta-endorphin and increased pain sensitivity in patients with functional abdominal pain.." Scandinavian journal of gastroenterology, 1993.

RethinkPeptides

RethinkPeptides Research Database. "Decreased cerebrospinal fluid beta-endorphin and increased p..." RPEP-00265. Retrieved from https://rethinkpeptides.com/research/jorgensen-1993-decreased-cerebrospinal-fluid-betaendorphin

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.